Clinical Trials Directory

Trials / Sponsors / Asklepion Pharmaceuticals, LLC

Asklepion Pharmaceuticals, LLC

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Eme
Sickle Cell Disease
Phase 32025-07-25
TerminatedA Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute
Ventricular Septal Defect, Atrioventricular Septal Defect, Primum Atrial Septal Defect
Phase 32022-06-29
TerminatedL-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive
Acute Vaso Occlusive Crisis (VOC)
Phase 1 / Phase 22021-04-29
CompletedIntravenous L-Citrulline Influence on the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respira
Acute Hypoxemic Respiratory Failure
Phase 22020-10-15
CompletedL-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass f
Acute Lung Injury
Phase 32016-08-01
CompletedIntravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
Atrial Septal Defect, Ventricular Septal Defect, Atrioventricular Septal Defect
Phase 1 / Phase 22010-09-01
CompletedIntravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery
Heart Defects, Congenital, Hypertension, Pulmonary
Phase 32006-05-01